Cholestasis in late metabolic acidosis of prematurely born infants

H Senger1, G Boehm, K Beyreiss

  • 1Department of Pediatrics, Karl-Marx University Leipzig, GDR.

Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie
|July 1, 1987
PubMed

Insights

Metabolic acidosis in premature infants disrupts bile acid and tyrosine levels, leading to impaired fat digestion. Treatment normalized these levels, improving infant health.

Area of Science:

  • Biochemistry
  • Pediatric Gastroenterology
  • Neonatology

Background:

  • Premature infants are susceptible to metabolic acidosis.
  • Metabolic acidosis can affect various physiological processes, including digestion and nutrient absorption.

Purpose of the Study:

  • To investigate the impact of late metabolic acidosis on bile acid and tyrosine metabolism in premature infants.
  • To assess the effects of metabolic acidosis on digestive enzyme activity and fat excretion.
  • To evaluate the recovery of these parameters after acidosis resolution.

Main Methods:

  • Serum bile acids and tyrosine were measured in infants with and without metabolic acidosis.
  • Duodenal juice analysis included bile acid concentration and lipase/trypsin activity.
  • Fecal fat excretion was quantified.
  • Duodenal studies were repeated in a subset of patients after acidosis correction.

Main Results:

  • Infants with metabolic acidosis exhibited significantly higher serum bile acids and tyrosine.
  • Decreased duodenal bile acids, lipase, and trypsin activity were observed during acidosis.
  • Increased fecal fat excretion was associated with metabolic acidosis.
  • Duodenal parameters normalized within a week after acidosis resolution.

Conclusions:

  • Late metabolic acidosis in premature infants is linked to cholestasis and altered amino acid transport.
  • Digestive enzyme deficiencies and impaired fat absorption are consequences of metabolic acidosis.
  • Correction of metabolic acidosis leads to the recovery of gastrointestinal function.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...